文献速递医学教育与科研方法临床试验与 GCP

2017年全球研究生物伦理论坛:中低收入国家研究中替代临床试验设计与方法的伦理议题

The global forum on bioethics in research meeting, "ethics of alternative clinical trial designs and methods in low- and middle-income country research": emerging themes and outputs.
PubMed 文献 · Trials · 2019-12-19

替代临床试验设计(如适应性、整群随机、阶梯楔形设计和控制性人类感染模型)在高收入及中低收入国家研究中日益使用,但研究者、伦理委员会和监管者对其伦理影响认识不足。2017年全球研究生物伦理论坛以此为主题,开启全球对话并突出中低收入国家视角,识别出需多学科方法并建设研究者、伦理委员会和监管者能力,以提出、审查和监管这些新设计和方法。

要点

  • 替代临床试验设计可提高效率和社会可接受性,但伦理影响未获充分关注。
  • 需多学科方法并建设中低收入国家研究者、伦理委员会和监管者能力。
  • 能力建设可帮助选择最科学、高效、伦理且符合情境的设计和方法。

核心结论

  • 替代临床试验设计和方法在中低收入国家研究中日益使用,但其伦理影响需全球对话和能力建设。
  • GFBR 2017会议旨在促进适当且伦理地使用新设计和方法,以实现其满足中低收入国家健康需求的潜力。

研究设计与样本

  • 2017年全球研究生物伦理论坛(GFBR)会议,主题为“中低收入国家研究中替代临床试验设计与方法的伦理”。

主要发现

  • 替代设计包括适应性、整群随机、阶梯楔形设计和控制性人类感染模型,可能更高效且社会可接受性更高。
  • 这些设计和方法对研究者、伦理委员会和监管者不熟悉,其伦理影响未获足够国际关注。
  • 会议识别出需多学科方法并建设研究者、伦理委员会和监管者能力,以提出、审查和监管这些新设计和方法。

临床怎么用

  • 鼓励广泛辩论,促进适当且伦理地使用新设计和方法。
  • 建设中低收入国家研究者、伦理委员会和监管者能力,以选择最科学、高效、伦理且符合情境的设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alternative clinical trial designs and methods are increasingly being used in place of the conventional individually randomised controlled trial (RCT) in high-income and in low-income and middle-income country (LMIC) research. These approaches - including adaptive, cluster-randomised and stepped-wedge designs and controlled human infection models - offer a number of potential advantages, including being more efficient and making the clinical trial process more socially acceptable. However, these designs and methods are generally not familiar to researchers, research ethics committees and regulators and their ethical implications have not received sufficient international attention from the bioethics, research, and policymaking communities working together. The ethics of alternative clinical trial designs and methods in LMIC research was chosen as a topic for the 2017 Global Forum on Bioethics in Research (GFBR). The meeting opened a global dialogue about this emerging issue in research ethics and gave voice to the LMIC perspective. It identified the need to take a multidisciplinary approach and to develop capacity amongst researchers and research ethics committees and regulators to propose, review and regulate these novel designs and methods. Building skills and infrastructure will empower researchers to choose from a broad range of designs and methods and adopt the most scientifically suitable, efficient, ethical and context-appropriate of these. The need for capacity development is most pressing from the LMIC perspective, where limited resources create an urgency to seek the most efficient trial design and method. The aim of this paper is to encourage broad debate about this complex area of research. By opening up this debate, GFBR aims to promote the appropriate and ethical use of novel designs and methods so their full potential to address the health needs in LMICs can be realised.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hunt A, Saenz C, Littler K, et al. The global forum on bioethics in research meeting, "ethics of alternative clinical trial designs and methods in low- and middle-income country research": emerging themes and outputs. Trials. 2019. PMID: 31852514. doi:10.1186/s13063-019-3840-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。